- Home
- BSBK vs TNYA Comparison
BSBK vs TNYA Comparison
Compare BSBK & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSBK
- TNYA
- Stock Information
- Founded
- BSBK 1893
- TNYA 2016
- Country
- BSBK United States
- TNYA United States
- Employees
- BSBK N/A
- TNYA N/A
- Industry
- BSBK Banks
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- BSBK Finance
- TNYA Health Care
- Exchange
- BSBK Nasdaq
- TNYA Nasdaq
- Market Cap
- BSBK 103.3M
- TNYA 119.2M
- IPO Year
- BSBK N/A
- TNYA 2021
- Fundamental
- Price
- BSBK $7.79
- TNYA $1.47
- Analyst Decision
- BSBK
- TNYA Strong Buy
- Analyst Count
- BSBK 0
- TNYA 4
- Target Price
- BSBK N/A
- TNYA $17.33
- AVG Volume (30 Days)
- BSBK 6.6K
- TNYA 6.3M
- Earning Date
- BSBK 02-04-2025
- TNYA 11-06-2024
- Dividend Yield
- BSBK N/A
- TNYA N/A
- EPS Growth
- BSBK N/A
- TNYA N/A
- EPS
- BSBK N/A
- TNYA N/A
- Revenue
- BSBK $12,132,417.00
- TNYA N/A
- Revenue This Year
- BSBK N/A
- TNYA N/A
- Revenue Next Year
- BSBK N/A
- TNYA N/A
- P/E Ratio
- BSBK N/A
- TNYA N/A
- Revenue Growth
- BSBK N/A
- TNYA N/A
- 52 Week Low
- BSBK $6.40
- TNYA $0.99
- 52 Week High
- BSBK $8.66
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- BSBK 43.10
- TNYA 38.04
- Support Level
- BSBK $7.54
- TNYA $1.43
- Resistance Level
- BSBK $7.96
- TNYA $1.63
- Average True Range (ATR)
- BSBK 0.24
- TNYA 0.13
- MACD
- BSBK 0.02
- TNYA 0.02
- Stochastic Oscillator
- BSBK 46.27
- TNYA 36.62
About BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from, customers in New Jersey.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.